Electromed, Inc. Launches SmartVest Connect Mobile Application
March 10 2020 - 4:30PM
Business Wire
Electromed, Inc. (NYSE American: ELMD) today announced the
launch of its SmartVest Connect® App for iOS and Android, a
personalized high frequency chest wall oscillation (HFCWO) therapy
management portal for patients with compromised pulmonary function.
The SmartVest Connect app securely connects to the SmartVest® SQL®
through Bluetooth™ technology. This interface allows patients and
healthcare teams to track therapy in real-time and collaborate on
care decisions to improve therapy adherence and patient
outcomes.
Available for download on the App Store and Google Play, the
SmartVest Connect app allows patients to more seamlessly connect
with their SmartVest therapy and offers new capabilities designed
for mobile, including setting personal therapy reminders and
real-time therapy monitoring.
“Since launch in 2017, SmartVest Connect has enhanced treatment
plans for patients with bronchiectasis and other chronic lung
conditions that require ongoing airway clearance therapy,”
commented Kathleen Skarvan, President and Chief Executive Officer
of Electromed. “Beginning today, patients can enjoy the benefits of
staying connected to their HFCWO therapy right from their mobile
device.”
Patients currently using SmartVest Connect can access their
account through the SmartVest Connect app. Once downloaded from the
App Store or Google Play, patients will receive their therapy
performance metrics automatically. During each new therapy session,
patients can view real-time data from their mobile device and set
helpful therapy reminders that fit their lifestyle.
Skarvan continued: “As our mission is to help patients breathe
easier and live better by providing effective, market-driven HFCWO
solutions, this new feature will enhance our customers’ experiences
and allow them to take a more active role in their therapy,
monitoring performance wherever life takes them next.”
About Electromed, Inc.
Electromed manufactures, markets, and sells products that
provide airway clearance therapy, including the SmartVest® Airway
Clearance System, to patients with compromised pulmonary function.
The Company is headquartered in New Prague, Minnesota and was
founded in 1992. Further information about Electromed can be found
at www.smartvest.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200310005649/en/
Kathleen Skarvan President and Chief Executive Officer
kskarvan@electromed.com 952-758-9299
Electromed (AMEX:ELMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Electromed (AMEX:ELMD)
Historical Stock Chart
From Sep 2023 to Sep 2024